Global Toxicology Drug Screening Market Size Study, by Product Type, by Test Type, by Technology Type, by End Users and Regional Forecasts 2022-2032

PUBLISHED: October 8, 2024

PAGES: 285 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global Toxicology Drug Screening Market is valued at approximately USD 15.31 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.04% over the forecast period 2024-2032. Toxicology drug screening is a diagnostic process used to detect and identify the presence of drugs, toxins, or other harmful substances in biological samples such as urine, blood, or saliva. This screening is essential for assessing exposure to potentially hazardous substances, determining drug use compliance, and evaluating potential poisoning or overdose cases. The process involves various analytical techniques, including immunoassays, gas chromatography, and mass spectrometry, to ensure accurate and reliable results. Furthermore, Ongoing innovations and advancements in analytical technologies are also expanding the toxicology drug screening market. High-throughput screening platforms, point-of-care testing, and rapid screening devices have made drug detection solutions more rapid, accurate, and cost-effective. Additionally, the integration of technologies such as mass spectrometry, chromatography, and immunoassays has improved the sensitivity and specificity of drug screening assays. Portable and smartphone-compatible testing devices have further enhanced the convenience of on-site testing in various settings, contributing to market growth.

The rising prevalence of drug abuse, stricter laws, and advancements in analytical technologies are the key market drivers enhancing market growth. The market for toxicology drug screening is driven by the growing prevalence of substance abuse, which poses significant health and social problems globally. The World Health Organization (WHO) estimates that 269 million people used drugs in 2018, with opioid-related deaths rising alarmingly. This has led governments, healthcare providers, and employers to increasingly adopt toxicology drug screening solutions to identify and prevent drug abuse, propelling market expansion. Government agencies and regulatory bodies are enforcing strict regulations that compel various industries to implement comprehensive drug screening programs. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce guidelines to ensure workplace safety and drug development efficacy. Consequently, sectors such as sports, healthcare, and transportation are mandated to conduct drug testing to uphold integrity and safety standards, driving the demand for toxicology drug screening products.

The key regions considered for the global toxicology drug screening market study include North America, Europe, Asia-Pacific, and the Rest of the World. North America dominates the market due to the high prevalence of drug abuse, stringent regulatory frameworks, and the presence of major market participants investing in advanced screening technologies. Europe holds the second-largest market share, driven by the increasing prevalence of substance abuse and rising investments in R&D activities. The Asia-Pacific region is expected to grow at the fastest CAGR, driven by the growing pharmaceutical and biotechnology sectors, increasing disposable incomes, rising healthcare expenditures, and growing awareness of the dangers of drug abuse.

Major market players included in this report are:

Agilent Technologies, Inc.
Covance, Inc.
Bio-Rad Laboratories, Inc.
BioReliance, Inc.
Thermo Fisher Scientific, Inc.
Eurofins Scientific SE
GE Healthcare
General Electric Company
Quest Diagnostics
Alere, Inc.
Enzo Life Sciences, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product Type:

Monitoring and Logging
Security
Storage and Continuous Integration/Continuous Deployment
Management and Orchestration
Networking and Data Management Services
Others

By Test Type:

Acute Systemic Toxicity
Dermal Toxicity
Carcinogenicity
Ocular Toxicity
Genotoxicity
Neurotoxicity
Organ-Specific Toxicity

By Technology Type:

High-Throughput Screening
Genomics
Transcriptomics
Toxicogenomics
Molecular Screening

By End Users:

Hospitals and Trauma Centers
Forensic Laboratories
Diagnostic Laboratories
Rehabilitation Centers
Pharmaceutical & Biotechnology Companies

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Toxicology Drug Screening Market Executive Summary

1.1. Global Toxicology Drug Screening Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product Type
- 1.3.2. By Test Type
- 1.3.3. By Technology Type
- 1.3.4. By End Users
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Toxicology Drug Screening Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Toxicology Drug Screening Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Prevalence of Drug Abuse
- 3.1.2. Stricter Laws and Regulations
- 3.1.3. Advancements in Analytical Technologies
3.2. Market Challenges
- 3.2.1. High Cost of Screening Technologies
- 3.2.2. Regulatory Hurdles
3.3. Market Opportunities
- 3.3.1. Integration of Advanced Technologies
- 3.3.2. Expansion in Emerging Markets

Chapter 4. Global Toxicology Drug Screening Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Toxicology Drug Screening Market Size & Forecasts by Product Type 2022-2032

5.1. Segment Dashboard
5.2. Global Toxicology Drug Screening Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Monitoring and Logging
- 5.2.2. Security
- 5.2.3. Storage and Continuous Integration/Continuous Deployment
- 5.2.4. Management and Orchestration
- 5.2.5. Networking and Data Management Services
- 5.2.6. Others

Chapter 6. Global Toxicology Drug Screening Market Size & Forecasts by Test Type 2022-2032

6.1. Segment Dashboard
6.2. Global Toxicology Drug Screening Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Acute Systemic Toxicity
- 6.2.2. Dermal Toxicity
- 6.2.3. Carcinogenicity
- 6.2.4. Ocular Toxicity
- 6.2.5. Genotoxicity
- 6.2.6. Neurotoxicity
- 6.2.7. Organ-Specific Toxicity

Chapter 7. Global Toxicology Drug Screening Market Size & Forecasts by Technology Type 2022-2032

7.1. Segment Dashboard
7.2. Global Toxicology Drug Screening Market: Technology Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. High-Throughput Screening
- 7.2.2. Genomics
- 7.2.3. Transcriptomics
- 7.2.4. Toxicogenomics
- 7.2.5. Molecular Screening

Chapter 8. Global Toxicology Drug Screening Market Size & Forecasts by End Users 2022-2032

8.1. Segment Dashboard
8.2. Global Toxicology Drug Screening Market: End Users Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Hospitals and Trauma Centers
- 8.2.2. Forensic Laboratories
- 8.2.3. Diagnostic Laboratories
- 8.2.4. Rehabilitation Centers
- 8.2.5. Pharmaceutical & Biotechnology Companies

Chapter 9. Global Toxicology Drug Screening Market Size & Forecasts by Region 2022-2032

9.1. North America Toxicology Drug Screening Market
- 9.1.1. U.S. Toxicology Drug Screening Market
  - 9.1.1.1. Product Type breakdown size & forecasts, 2022-2032
  - 9.1.1.2. Test Type breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Technology Type breakdown size & forecasts, 2022-2032
  - 9.1.1.4. End Users breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Toxicology Drug Screening Market
9.2. Europe Toxicology Drug Screening Market
- 9.2.1. U.K. Toxicology Drug Screening Market
- 9.2.2. Germany Toxicology Drug Screening Market
- 9.2.3. France Toxicology Drug Screening Market
- 9.2.4. Spain Toxicology Drug Screening Market
- 9.2.5. Italy Toxicology Drug Screening Market
- 9.2.6. Rest of Europe Toxicology Drug Screening Market
9.3. Asia-Pacific Toxicology Drug Screening Market
- 9.3.1. China Toxicology Drug Screening Market
- 9.3.2. India Toxicology Drug Screening Market
- 9.3.3. Japan Toxicology Drug Screening Market
- 9.3.4. Australia Toxicology Drug Screening Market
- 9.3.5. South Korea Toxicology Drug Screening Market
- 9.3.6. Rest of Asia-Pacific Toxicology Drug Screening Market
9.4. Latin America Toxicology Drug Screening Market
- 9.4.1. Brazil Toxicology Drug Screening Market
- 9.4.2. Mexico Toxicology Drug Screening Market
- 9.4.3. Rest of Latin America Toxicology Drug Screening Market
9.5. Middle East & Africa Toxicology Drug Screening Market
- 9.5.1. Saudi Arabia Toxicology Drug Screening Market
- 9.5.2. South Africa Toxicology Drug Screening Market
- 9.5.3. Rest of Middle East & Africa Toxicology Drug Screening Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Agilent Technologies, Inc.
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. Covance, Inc.
- 10.3.3. Bio-Rad Laboratories, Inc.
- 10.3.4. BioReliance, Inc.
- 10.3.5. Thermo Fisher Scientific, Inc.
- 10.3.6. Eurofins Scientific SE
- 10.3.7. GE Healthcare
- 10.3.8. General Electric Company
- 10.3.9. Quest Diagnostics
- 10.3.10. Alere, Inc.
- 10.3.11. Enzo Life Sciences, Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes